Related Experiment Video
Updated: Sep 27, 2025

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in
1Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei Province, China.
Abstract:
Long non-coding RNA (lncRNA) OPA-interacting protein 5 antisense transcript 1 (OIP5-AS1) plays an oncogenic role in several types of cancer, but whether it is involved in non-small-cell lung cancer (NSCLC) is unclear. Our preliminary sequencing analysis revealed the upregulation of OIP5-AS1 in NSCLC. In this study, gene expression levels were analyzed by RT-qPCR. RNA-RNA pull-down assay was applied to detect direct interactions between RNAs. Overexpression assays were performed to explore the relationship between miR-34a and OIP5-AS1. CCK-8 assay and colony formation assay were applied to evaluate cell proliferation. In NSCLC cells (H23), overexpression of OIP5-AS1 increased the expression levels of programmed death-ligand 1 (PD-L1). In addition, inhibition of OIP5-AS1 and overexpression of miR-34a decreased the expression levels of PD-L1, and miR-34a significantly blocked the role of overexpression of OIP5-AS1. Overexpression of OIP5-AS1 and PD-L1 promoted H23 and H22 cells proliferation, while silencing of miR-34a and OIP5-AS1 played opposite roles and eliminated the effects of overexpression of OIP5-AS1 on cell proliferation. Therefore, OIP5-AS1 was upregulated to enhance the expression of oncogenic PD-L1 by sponging miR-34a in NSCLC, leading to promoted NSCLC cell proliferation. Our study also demonstrated that OIP5-AS1 was upregulated while miR-34a was downregulated in NSCLC.
Insights
Long non-coding RNA OIP5-AS1 is upregulated in non-small-cell lung cancer (NSCLC), promoting cancer cell proliferation by increasing PD-L1 via sponging miR-34a.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNA (lncRNA) OPA-interacting protein 5 antisense transcript 1 (OIP5-AS1) has an oncogenic role in various cancers.
- The involvement of OIP5-AS1 in non-small-cell lung cancer (NSCLC) remains largely uncharacterized.
- Preliminary data indicate OIP5-AS1 is upregulated in NSCLC tissues.
Purpose of the Study:
- To investigate the role of OIP5-AS1 in NSCLC.
- To elucidate the molecular mechanism by which OIP5-AS1 influences NSCLC progression.
- To explore the relationship between OIP5-AS1, miR-34a, and programmed death-ligand 1 (PD-L1) in NSCLC.
Main Methods:
- Gene expression analysis using RT-qPCR.
- RNA-RNA pull-down assays to confirm direct RNA interactions.
- Cell proliferation assays (CCK-8, colony formation).
- Overexpression and inhibition studies of OIP5-AS1 and miR-34a.
Main Results:
- OIP5-AS1 expression is significantly upregulated in NSCLC.
- OIP5-AS1 overexpression increases PD-L1 levels and promotes NSCLC cell proliferation.
- OIP5-AS1 acts as a sponge for miR-34a, inhibiting its function.
- miR-34a inhibition or OIP5-AS1 silencing reverses the pro-proliferative effects and PD-L1 upregulation.
Conclusions:
- OIP5-AS1 promotes NSCLC cell proliferation by upregulating oncogenic PD-L1 through sponging miR-34a.
- OIP5-AS1 and miR-34a are dysregulated in NSCLC, suggesting their potential as therapeutic targets.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
piRNA - Piwi-interacting RNAs
Experimental RNAi
Types of RNA
RNA Performs Diverse...

